Similar to mice, inhibition of vanin activity did not affect bodyweight (Fig. 4A), food intake (Supplementary Fig. S2B) or hepatic steatosis as measured by TG levels (Fig. 4B), supported by similar expression of hepatic PPARγ (Supplementary Fig. S5A,D). Here, PPARG is linked to fatty liver disease.